Biomarin Pharmaceuticals (BMRN)
$84.20 1.87 (2.17%)
13:13 EDT BMRN Stock Quote Delayed 20 Minutes
Previous Close $86.06
Market Cap 14.88B
PE Ratio -100.23
Volume (Avg. Vol.) 391,801
Day's Range 84.17 - 87.25
52-Week Range 62.88 - 97.10
Dividend & Yield N/A (N/A)
BMRN Stock Predictions, Articles, and Biomarin Pharmaceuticals News
- From InvestorPlace
- From the Web
We are now approaching the second half of 2019. And it may be time for a little portfolio rebalancing. Biotech stocks often move independently from the market, and these 5 are worth a look.
These takeover stocks all look like promising takeover targets at a time when M&A activity is likely to pick up.
We take a look at three biotech stocks whose share price has increased in the past month due to as the biotech industry bounced back in the past month after dec....
Though the biotech industry is down this year, there are still a few stocks which can strengthen your portfolio. Compare Brokers....
Biotech stocks are only as good as their pipeline. These five biotech companies are about to put out promising new drugs, with more products in the works.
BioMarin (BMRN) stock was on the rise today following positive news for its gene therapy efforts to treat severe hemophilia.
Portfolio Grader currently ranks BioMarin Pharmaceuticals (NASDAQ:BMRN) a Sell. Using Louis Navellier's investing methodology, this analytical tool researches stocks by means of fundamental and quantitative analytical tools. BMRN has maintained this ranking for 4 months.
3 Big Stock Charts for Wednesday: Twilio Inc (TWLO), BioMarin Pharmaceutical Inc. (BMRN) and Mondelez International Inc (MDLZ)
BioMarin Pharmaceutical (BMRN), Mondelez International (MDLZ) and Twilio (TWLO) are all teetering on the brink of bearish signals.
These five top biotech stocks have the seal of approval from the Street, with 'strong buy' analyst consensus ratings and big upside.
Here's a look at three biotech stocks that have at least one treatment prepped to enter pivotal clinical trials soon.
Biotechs have stabilized and offer the potential to deliver substantial returns. Here are 5 biotech stocks that fit our investment criteria
This week, the overall grades of 23 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Why Wayfair Inc (W), BioMarin Pharmaceutical Inc. (BMRN) and Norwegian Cruise Line Holdings Ltd (NCLH) Are 3 of Today’s Worst Stocks
Owners of BioMarin Pharmaceutical (BMRN), Norwegian Cruise Line (NCLH) and Wayfair (W) were less than thrilled on Tuesday.
BioMarin Pharmaceutical Inc. broke from a triple-top on high volume.
Why BioMarin Pharmaceutical Inc. (BMRN), Western Digital Corp (WDC) and WhiteWave Foods Co (WWAV) Are 3 of Today’s Best Stocks
Takeover talk and improved earnings guidance made BMRN, WDC and WWAV three of Thursday's best performers.
The following stocks were moving the Manufacturing sector today.
Why American Airlines Group Inc (AAL), BioMarin Pharmaceutical Inc. (BMRN) and Cavium Inc (CAVM) Are 3 of Today’s Worst Stocks
Too bad for owners of American Airlines (AAL), BioMarin Pharmaceutical (BMRN) and Cavium (CAVM) the market doesn't do do-overs.
From Simply Wall St
Ideally, your overall portfolio should beat the market average. But even the best stock picker will only win with some selections. So we wouldn’t blame long term BioMarin Pharmaceutical Inc.<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bmrn/biomarin-pharmaceutical/news/did-changing-sentiment-drive-biomarin-pharmaceuticals-nasdaqbmrn-share-price-down-by-30/">Read More...</a></div>
From Seeking Alpha
Navellier RatingsPowered by Portfolio Grader